Reinisch, M., Untch, M., Mahlberg, R., Reimer, T., Hitschold, T., Marmé, F., . . . Loibl, S. (2022). Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference : substudy of the randomised phase III GAIN-2 study. The breast, 66, . https://doi.org/10.1016/j.breast.2022.10.002
Chicago-Zitierstil (17. Ausg.)Reinisch, Mattea, et al. "Subcutaneous Injection of Trastuzumab into the Thigh Versus Abdominal Wall in Patients with HER2-positive Early Breast Cancer: Pharmacokinetic, Safety and Patients' Preference : Substudy of the Randomised Phase III GAIN-2 Study." The Breast 66 (2022). https://doi.org/10.1016/j.breast.2022.10.002.
MLA-Zitierstil (9. Ausg.)Reinisch, Mattea, et al. "Subcutaneous Injection of Trastuzumab into the Thigh Versus Abdominal Wall in Patients with HER2-positive Early Breast Cancer: Pharmacokinetic, Safety and Patients' Preference : Substudy of the Randomised Phase III GAIN-2 Study." The Breast, vol. 66, 2022, https://doi.org/10.1016/j.breast.2022.10.002.